| Structure-activity relationship of mutagenic aromatic and heteroaromatic nitro compounds. correlation with molecular orbital energies and hydrophobicity AK Debnath, RL Lopez de Compadre, G Debnath, AJ Shusterman, ... Journal of medicinal chemistry 34 (2), 786-797, 1991 | 752 | 1991 |
| Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion … S Liu, G Xiao, Y Chen, Y He, J Niu, CR Escalante, H Xiong, J Farmar, ... The Lancet 363 (9413), 938-947, 2004 | 529 | 2004 |
| Comparative quantitative structure− activity relationship studies on anti-HIV drugs R Garg, SP Gupta, H Gao, MS Babu, AK Debnath, C Hansch Chemical reviews 99 (12), 3525-3602, 1999 | 364 | 1999 |
| N-substituted pyrrole derivatives as novel human immunodeficiency virus type 1 entry inhibitors that interfere with the gp41 six-helix bundle formation and block virus fusion S Jiang, H Lu, S Liu, Q Zhao, Y He, AK Debnath Antimicrobial agents and chemotherapy 48 (11), 4349-4359, 2004 | 314 | 2004 |
| Structure-based identification of small molecule antiviral compounds targeted to the gp41 core structure of the human immunodeficiency virus type 1 AK Debnath, L Radigan, S Jiang Journal of medicinal chemistry 42 (17), 3203-3209, 1999 | 285 | 1999 |
| Unliganded HIV-1 gp120 core structures assume the CD4-bound conformation with regulation by quaternary interactions and variable loops Y Do Kwon, A Finzi, X Wu, C Dogo-Isonagie, LK Lee, LR Moore, ... Proceedings of the National Academy of Sciences 109 (15), 5663-5668, 2012 | 248 | 2012 |
| Design of a Protein Surface Antagonist Based on α‐Helix Mimicry: Inhibition of gp41 Assembly and Viral Fusion JT Ernst, O Kutzki, AK Debnath, S Jiang, H Lu, AD Hamilton Angewandte Chemie International Edition 41 (2), 278-281, 2002 | 235 | 2002 |
| Identification of N-phenyl-N′-(2, 2, 6, 6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4 Q Zhao, L Ma, S Jiang, H Lu, S Liu, Y He, N Strick, N Neamati, ... Virology 339 (2), 213-225, 2005 | 234 | 2005 |
| A cell-penetrating helical peptide as a potential HIV-1 inhibitor H Zhang, Q Zhao, S Bhattacharya, AA Waheed, X Tong, A Hong, S Heck, ... Journal of molecular biology 378 (3), 565-580, 2008 | 229 | 2008 |
| Theaflavin derivatives in black tea and catechin derivatives in green tea inhibit HIV-1 entry by targeting gp41 S Liu, H Lu, Q Zhao, Y He, J Niu, AK Debnath, S Wu, S Jiang Biochimica et Biophysica Acta (BBA)-General Subjects 1723 (1-3), 270-281, 2005 | 222 | 2005 |
| Identification of a receptor-binding domain in the S protein of the novel human coronavirus Middle East respiratory syndrome coronavirus as an essential target for vaccine … L Du, G Zhao, Z Kou, C Ma, S Sun, VKM Poon, L Lu, L Wang, AK Debnath, ... Journal of virology 87 (17), 9939-9942, 2013 | 198 | 2013 |
| A QSAR investigation of the role of hydrophobicity in regulating mutagenicity in the Ames test: 1. Mutagenicity of aromatic and heteroaromatic amines in Salmonella typhimurium … AK Debnath, G Debnath, AJ Shusterman, C Hansch Environmental and molecular mutagenesis 19 (1), 37-52, 1992 | 195 | 1992 |
| Peptide and non-peptide HIV fusion inhibitors S Jing, Q Zhao, AK Debnath Current pharmaceutical design 8 (8), 563-580, 2002 | 167 | 2002 |
| Pharmacophore mapping of a series of 2, 4-diamino-5-deazapteridine inhibitors of Mycobacterium avium complex dihydrofolate reductase AK Debnath Journal of medicinal chemistry 45 (1), 41-53, 2002 | 162 | 2002 |
| A screening assay for antiviral compounds targeted to the HIV-1 gp41 core structure using a conformation-specific monoclonal antibody S Jiang, K Lin, L Zhang, AK Debnath Journal of virological methods 80 (1), 85-96, 1999 | 147 | 1999 |
| Punica granatum (Pomegranate) juice provides an HIV-1 entry inhibitor and candidate topical microbicide AR Neurath, N Strick, YY Li, AK Debnath BMC infectious diseases 4 (1), 1-12, 2004 | 120 | 2004 |
| Design, synthesis, and structure− activity relationship of a novel series of 2-aryl 5-(4-oxo-3-phenethyl-2-thioxothiazolidinylidenemethyl) furans as HIV-1 entry inhibitors AR Katritzky, SR Tala, H Lu, AV Vakulenko, QY Chen, J Sivapackiam, ... Journal of medicinal chemistry 52 (23), 7631-7639, 2009 | 119 | 2009 |
| Cellulose acetate phthalate, a common pharmaceutical excipient, inactivates HIV-1 and blocks the coreceptor binding site on the virus envelope glycoprotein gp120 AR Neurath, N Strick, YY Li, AK Debnath BMC infectious diseases 1 (1), 1-12, 2001 | 112 | 2001 |
| Three-dimensional quantitative structure− activity relationship study on cyclic urea derivatives as HIV-1 protease inhibitors: Application of comparative molecular field analysis AK Debnath Journal of Medicinal Chemistry 42 (2), 249-259, 1999 | 111 | 1999 |
| Solution structure of a hydrocarbon stapled peptide inhibitor in complex with monomeric C-terminal domain of HIV-1 capsid S Bhattacharya, H Zhang, AK Debnath, D Cowburn Journal of Biological Chemistry 283 (24), 16274-16278, 2008 | 109 | 2008 |
Shibo JiangFudan UniversityVerified email at fudan.edu.cn
